hydroxychloroquine has been researched along with Fasting Hypoglycemia in 8 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Fasting Hypoglycemia: HYPOGLYCEMIA expressed in the postabsorptive state, after prolonged FASTING, or an overnight fast.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Several case reports have highlighted symptomatic hypoglycemia as a serious but uncommon adverse effect of hydroxychloroquine (HCQ) in nondiabetic subjects." | 7.96 | Hypoglycemia Induced by Hydroxychloroquine Sulfate in a Patient Treated for Connective Tissue Disease Without Diabetes Mellitus. ( Dai, Y; Lin, G; Shi, D, 2020) |
| "To determine the relationship between current hydroxychloroquine (HCQ) use and 2 indicators of glycemic control, fasting glucose and insulin sensitivity, in nondiabetic women with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA)." | 7.76 | Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus. ( Elliott, JR; Kao, AH; Kuller, L; Manzi, S; Penn, SK; Schott, LL; Toledo, FG; Wasko, MC, 2010) |
| "Hydroxychloroquine has been reported to reduce insulin requirements in refractory type II diabetes by an average of 30%." | 5.30 | Hypoglycemia induced by hydroxychloroquine in a type II diabetic treated for polyarthritis. ( Elliott, T; Koehler, BE; Shojania, K, 1999) |
| "Several case reports have highlighted symptomatic hypoglycemia as a serious but uncommon adverse effect of hydroxychloroquine (HCQ) in nondiabetic subjects." | 3.96 | Hypoglycemia Induced by Hydroxychloroquine Sulfate in a Patient Treated for Connective Tissue Disease Without Diabetes Mellitus. ( Dai, Y; Lin, G; Shi, D, 2020) |
| "To determine the relationship between current hydroxychloroquine (HCQ) use and 2 indicators of glycemic control, fasting glucose and insulin sensitivity, in nondiabetic women with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA)." | 3.76 | Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus. ( Elliott, JR; Kao, AH; Kuller, L; Manzi, S; Penn, SK; Schott, LL; Toledo, FG; Wasko, MC, 2010) |
| "Hydroxychloroquine (HCQ) is a commonly used drug for the treatment of systemic lupus erythematosus (SLE)." | 2.58 | Hydroxychloroquine-induced hypoglycaemia in non-diabetic renal patient on peritoneal dialysis. ( Ai-Hwiesh, AK; Al-Otaibi, K; El-Solia, A, 2018) |
| "Hydroxychloroquine has been reported to reduce insulin requirements in refractory type II diabetes by an average of 30%." | 1.30 | Hypoglycemia induced by hydroxychloroquine in a type II diabetic treated for polyarthritis. ( Elliott, T; Koehler, BE; Shojania, K, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y | 1 |
| Lin, G | 1 |
| Shi, D | 1 |
| El-Solia, A | 1 |
| Al-Otaibi, K | 1 |
| Ai-Hwiesh, AK | 1 |
| Penn, SK | 1 |
| Kao, AH | 1 |
| Schott, LL | 1 |
| Elliott, JR | 1 |
| Toledo, FG | 1 |
| Kuller, L | 1 |
| Manzi, S | 1 |
| Wasko, MC | 1 |
| Unübol, M | 1 |
| Ayhan, M | 1 |
| Guney, E | 1 |
| Winter, EM | 1 |
| Schrander-van der Meer, A | 1 |
| Eustatia-Rutten, C | 1 |
| Janssen, M | 1 |
| Cansu, DU | 1 |
| Korkmaz, C | 1 |
| Shojania, K | 1 |
| Koehler, BE | 1 |
| Elliott, T | 1 |
1 review available for hydroxychloroquine and Fasting Hypoglycemia
| Article | Year |
|---|---|
Hydroxychloroquine-induced hypoglycaemia in non-diabetic renal patient on peritoneal dialysis.
Topics: Adult; Antirheumatic Agents; Female; Humans; Hydroxychloroquine; Hypoglycemia; Lupus Nephritis; Peri | 2018 |
7 other studies available for hydroxychloroquine and Fasting Hypoglycemia
| Article | Year |
|---|---|
Hypoglycemia Induced by Hydroxychloroquine Sulfate in a Patient Treated for Connective Tissue Disease Without Diabetes Mellitus.
Topics: Adult; Antirheumatic Agents; Blood Glucose; Connective Tissue Diseases; Dizziness; Fatigue; Female; | 2020 |
Hydroxychloroquine: hypoglycaemia.
Topics: Antimalarials; Blood Glucose; Humans; Hydroxychloroquine; Hypoglycemia; Immunosuppressive Agents; Ri | 2015 |
Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Blood Glucose; Cross-Sectional Studies; Diabetes Mellit | 2010 |
Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Glucose; Diabetes Mellitus; Female; Humans; | 2011 |
Hydroxychloroquine as a glucose lowering drug.
Topics: Aged, 80 and over; Antimalarials; Female; Humans; Hydroxychloroquine; Hypoglycemia; Withholding Trea | 2011 |
Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA.
Topics: Arthritis, Rheumatoid; Blood Glucose; Dose-Response Relationship, Drug; Drug Administration Schedule | 2008 |
Hypoglycemia induced by hydroxychloroquine in a type II diabetic treated for polyarthritis.
Topics: Aged; Antirheumatic Agents; Arthritis; Diabetes Mellitus, Type 2; Humans; Hydroxychloroquine; Hypogl | 1999 |